Jupiter Life Line Hospitals is currently trading at Rs. 1244.25, up by 4.65 points or 0.38% from its previous closing of Rs. 1239.60 on the BSE.
The scrip opened at Rs. 1242.50 and has touched a high and low of Rs. 1253.85 and Rs. 1231.10 respectively. So far 1424 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 10 has touched a 52 week high of Rs. 1648.60 on 23-Feb-2024 and a 52 week low of Rs. 960.00 on 18-Sep-2023.
Last one week high and low of the scrip stood at Rs. 1260.00 and Rs. 1214.00 respectively. The current market cap of the company is Rs. 8127.56 crore.
The promoters holding in the company stood at 40.91%, while Institutions and Non-Institutions held 18.33% and 40.75% respectively.
Jupiter Life Line Hospitals has received approval for addition of 75 beds in the existing Indore Hospital and 22 beds in the existing Pune Hospital, Baner which is currently having capacity of 231 beds and 353 beds respectively.
Further with this addition, the total bed capacity at Indore hospital will be 306 beds and at Pune Hospital will be 375 beds. The beds will be operationalized by Q4FY25. The total project cost is approximately Rs 18 crore. This facility with added capacity will cater to the increasing demand at Indore for qualitative healthcare services. The Board of Directors of the company at its meeting held on May 10, 2024 has approved the same.
Jupiter Life Line Hospitals is engaged in the business of operating and managing hospitals and clinics in India. The company is among the key multi-specialty tertiary and quaternary healthcare providers.
